Investors
We are a world-leading company 100% focussed on everyday health. Our leading brands are built on science, innovation and human understanding and are trusted by millions of consumers globally. Our purpose is to deliver better everyday health with humanity.
Download the Haleon factsheet to learn more.
Dawn Allen assumed her role as Chief Financial Officer and Board member of Haleon in November 2024.
Dawn joined us from Tate & Lyle plc where she was CFO and member of the Executive Team and Board. Prior to this, Dawn spent 25 years at Mars Inc. where she was more recently Global CFO and Vice President of Global Transformation.
While Haleon may be a relatively new name, many of our brands have been loved and trusted for generations. Join the Investor Relations team as we deep dive into some of these brands; showcasing their history and innovation.
Tums: Looking closer at the brand’s history, innovation, and marketing, which combined with efficacy addresses a real health need of heartburn, making it America’s number one antacid.
For the most up to date information on financial performance, shareholder services and more information.
Haleon has a strong portfolio of brands and is well positioned to play a vital role for people all around the world, in a sector that is growing and more relevant than ever.
If you are an institutional shareholder or equity analyst and would like information on Haleon, please contact our investor relations team.
1 In the medium term (see 2023 Annual Report for definitions)
2 Definitions can be found in the 2023 Annual Report
3 Free cash flow conversion (see 2023 Annual Report for definitions)
